Cardiovascular disease (CVD) is a major health problem, affecting millions of people globally. From hereditary conditions and lifestyle habits to societal and environmental contexts, our hearts face many concerns. While a healthy lifestyle may slow down the progression of CVD, sometimes, more needs to be done. If necessary, your doctor may decide that lifestyle changes need to be augmented with other treatment options, to reduce elevated low-density lipoprotein cholesterol (LDL-C) levels.3 However, despite appropriate interventions, many patients' heart health may remain at risk. This is why our ambition at Amarin is to be a part of the solution in addressing this important health issue. Always consult with your healthcare professional who is best placed to advise on any personal medical matters.
For medical questions, updated publications, information about our products or any other medical information, please submit your details here and a member of our Medical Affairs team will respond to you.
At Amarin, we’re committed to providing breakthrough treatments, scientific understanding and expertise.
Learn about our approved product.
Keeping our investors informed about our progress in helping stop cardiovascular disease from being a leading cause of death is important to us. Click here for our investor presentations, events and financial results.
Amarin Corporation is focused on a BOLD vision to stop cardiovascular disease from being a leading cause of death. Find out more about our vision and how we lead the way to better care for those with cardiovascular disease.
Are you interested in joining Amarin and being part of our BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide? Click here for more information about our culture, career opportunities, benefits and more.